Valuation: Alfresa Holdings Corporation

Market Cap 401B 2.47B 2.16B 2B 1.83B 3.48B 238B 3.54B 23.82B 9.35B 116B 9.29B 9.09B P/E 2027 *
17.6x
P/E 2028 * 14.1x
Enterprise Value 401B 2.47B 2.16B 2B 1.83B 3.48B 238B 3.54B 23.82B 9.35B 116B 9.29B 9.09B EV / Sales 2027 *
0.13x
EV / Sales 2028 * 0.12x
Free-Float
88.28%
Yield 2027 *
3.11%
Yield 2028 * 3.46%
Jun. 21 Alfresa Holdings Corporation(TSE:2784) dropped from S&P Japan Mid Cap 100 CI
May. 26 ReeNT Co., Ltd. announced that it expects to receive ¥600 million in funding from Alfresa Holdings Corporation CI
May. 26 Alfresa Holdings Corporation concluded a share transfer agreement to acquire Nagashima Medical Instruments Co., Ltd. from Nagashima Holdings Co., Ltd. CI
May. 18 Alfresa Holdings Corporation's Equity Buyback announced on May 15, 2026, has closed with 6,307,800 shares, representing 3.47% for ¥14,999.95 million. CI
May. 18 Tranche Update on Alfresa Holdings Corporation's Equity Buyback Plan announced on May 15, 2026. CI
May. 15 Alfresa Holdings Corporation authorizes a Buyback Plan. CI
May. 15 Alfresa Holdings Corporation announces an Equity Buyback for 6,307,800 shares, representing 3.46% for ¥14,999.95 million. CI
May. 15 Alfresa Holdings Corp - to buy back up to 3.5% of own shares worth about 15 billion yen RE
May. 15 Alfresa Holdings Corporation Announces Cash Dividend for the Year-End of the Fiscal Year Ended March 31, 2026, Payable on June 2, 2026; Provides Cash Dividend Guidance for the Second Quarter-End and Year-End of the Fiscal Year Ending March 31, 2027 CI
May. 15 Alfresa Holdings Corporation Provides Consolidated Earnings Guidance for the Six Months Ending September 30, 2026 and for the Fiscal Year Ending March 31, 2027 CI
Apr. 07 Healios Secures 144 Million Yen Initial Order from Alfresa's Korean Unit for Cosmetic Raw Material MT
Feb. 26 Alfresa Holdings Corporation concluded a share transfer agreement to acquire Techno Suzuta, Co.,Ltd. from Onsendo, K.K. CI
Feb. 10 Alfresa Books 15.4 Billion Yen Gain from Sale Of Investment Securities MT
1 day+2.72%
1 week+3.46%
Current month+5.17%
1 month+3.67%
3 months-7.09%
6 months-10.30%
Current year-5.94%
1 week 2,188.5
Extreme 2188.5
2,289
1 month 2,144.5
Extreme 2144.5
2,289
Current year 2,106.5
Extreme 2106.5
2,685.5
1 year 2,050.5
Extreme 2050.5
2,685.5
3 years 1,897
Extreme 1897
2,685.5
5 years 1,505
Extreme 1505
2,685.5
10 years 1,505
Extreme 1505
3,350
Manager TitleAgeSince
Chief Executive Officer 63 -
Chief Tech/Sci/R&D Officer 63 2022-06-27
Corporate Officer/Principal 61 2020-03-31
Director TitleAgeSince
Director/Board Member 50 2020-05-31
Director/Board Member 63 2007-05-31
Director/Board Member 72 2020-05-31
Change 5-day change 1-year change 3-year change Capi.($)
+2.72%+3.46%+10.70%+8.54% 2.41B
+1.06%-6.21%-32.11%-16.57% 155B
+1.48%-1.88%-9.81%-7.20% 102B
-1.89%-4.20%+0.65%+54.35% 58.81B
-0.94%-1.23%+39.41%+54.08% 52.82B
+2.81%+2.87%-13.14%-39.65% 41.51B
+2.02%-2.13% - - 32.69B
-1.88%-1.80%-14.21%-47.09% 28.6B
+0.38%+1.50%+62.41%-6.42% 25.27B
+1.31%+0.94%-7.59%-7.40% 20.34B
Average +0.83%-2.85%+4.03%-0.82% 51.89B
Weighted average by Cap. +0.67%-4.29%-6.90%-1.09%

Financials

2027 *2028 *
Net sales 3,164B 19.52B 17.07B 15.74B 14.47B 27.42B 1,878B 27.89B 188B 73.75B 918B 73.31B 71.7B 3,253B 20.07B 17.54B 16.18B 14.88B 28.19B 1,931B 28.67B 193B 75.81B 944B 75.35B 73.7B
Net income 25.25B 156M 136M 126M 115M 219M 14.99B 223M 1.5B 588M 7.32B 585M 572M 28.12B 173M 152M 140M 129M 244M 16.69B 248M 1.67B 655M 8.16B 651M 637M
Net Debt - -
Logo Alfresa Holdings Corporation
Alfresa Holdings Corporation is a Japan-based holding company primarily engaged in the wholesale of drugs. The Company operates in four business segments. The Pharmaceutical Wholesale segment is engaged in the wholesale of medical products, test reagents, as well as medical equipment and materials. The Self Medication Wholesale segment is engaged in the wholesale of general drugs. The Pharmaceutical Manufacture segment is engaged in the manufacture and sale of pharmaceuticals, test reagents, medical equipment and implements, as well as pharmaceutical powders. The Medical-Related segment is mainly engaged in operation of pharmacies. The others business is engaged in the information system business, the transportation business, the warehousing business, the insurance agency business, the real estate management business, the sale of miscellaneous goods, as well as the manpower dispatching business, among others.
Employees
12,525
Date Price Change Volume
26-07-15 ¥2,286.50 +2.72% 762,600
26-07-14 ¥2,226.00 +0.77% 459,000
26-07-13 ¥2,209.00 +0.34% 368,900
26-07-10 ¥2,201.50 -1.10% 715,900
26-07-09 ¥2,226.00 -0.20% 426,800
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
2,286.50JPY
Average target price
2,500.00JPY
Spread / Average Target
+9.34%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2784 Stock